Bisphosphonate and supplement adherence in postmenopausal osteoporosis
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This trial looks at how well women with postmenopausal osteoporosis follow their treatment plan, which includes a bisphosphonate taken once a week or once a month along with daily calcium and vitamin D supplements. The goal is to understand patterns that may help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman who has gone through menopause and have been diagnosed with osteoporosis.
- You have been prescribed a bisphosphonate (a type of bone-strengthening medicine) taken either every week or every month, along with daily calcium and vitamin D supplements.
- You have been taking this treatment for at least 6 months.
- You are able and willing to give written permission to be in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new form of calcium (amorphous calcium carbonate) to see if it can improve bone density in postmenopausal women with osteoporosis. It may offer an alternative for women who cannot or choose not to take other osteoporosis medications.
This trial tests a boron-based supplement called OsteoBor to see if it helps strengthen bones in postmenopausal women who have osteoporosis (low bone density). You would take OsteoBor or a placebo daily along with calcium and vitamin D.
This study compares two treatments for osteoporosis in postmenopausal women: a sequence of romosozumab followed by denosumab versus zoledronic acid alone. The goal is to see which approach better improves bone density in the hip. Participants will receive either the combination or the single drug for a period, and their progress will be monitored.
This trial tests a combination of vitamin K, D-chiro inositol, and α-lactalbumin to help maintain bone strength in women with breast cancer who are on hormone therapy and have low vitamin D. It aims to see if these supplements improve bone health while you take a standard bone medication (alendronate).
This study looks at how well your blood vessels work and how strong your muscles are, in women after menopause with osteoporosis. You may be asked to start standard osteoporosis treatment, and the researchers will study pain and changes related to vascular function and sarcopenia (loss of muscle and strength).
This trial looks at how exercise, alone or with osteoporosis medication, affects bone health in women after menopause. It may help you find a safe way to strengthen your bones.
Hear when a new Post Menopausal Osteoporosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.